Ardelyx (ARDX) Research & Development (2013 - 2026)

Ardelyx (ARDX) posted Research & Development of $20.2 million for Q1 2026, down 11.67% on a QoQ basis from $22.9 million in Q4 2025, and up 35.15% year-over-year from $14.9 million in Q1 2025.

Ardelyx (ARDX) Research & Development (2013 - 2026) Analysis & Trends

Ardelyx's Research & Development history runs 14 years deep, the most recent figure standing at $20.2 million for Q1 2026.

  • Quarterly Research & Development rose 35.15% year-over-year to $20.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $76.8 million (up 35.47% YoY) and the FY2025 annual result came in at $71.5 million, up 36.72% from the prior year.
  • Research & Development was $20.2 million for Q1 2026 at Ardelyx, down from $22.9 million in the prior quarter.
  • Across five years, Research & Development topped out at $22.9 million in Q4 2025 and bottomed at $7.5 million in Q3 2022.
  • A 5-year average of $12.6 million and a median of $10.6 million in 2024 frame the typical range for Research & Development.
  • Annual changes were most pronounced in 2022 — Research & Development tumbled 68.49% — and 2024, when it surged 77.26%.
  • Ardelyx's Research & Development stood at $9.1 million in 2022, then advanced by 4.18% to $9.5 million in 2023, then surged by 43.49% to $13.7 million in 2024, then soared by 67.25% to $22.9 million in 2025, then retreated by 11.67% to $20.2 million in 2026.
  • Business Quant data shows ARDX's Research & Development at $20.2 million in Q1 2026, $22.9 million in Q4 2025, and $18.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -17.94 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 1.46 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 541.22 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 961.60 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 1.54 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 15.66 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -443.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 343.97 Mn
10 Ardelyx 1.24 Bn 999.81 Mn 89.66 Mn 20.19 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 20.19 Mn
Dec 31, 2025 22.86 Mn
Sep 30, 2025 18.07 Mn
Jun 30, 2025 15.67 Mn
Mar 31, 2025 14.94 Mn
Dec 31, 2024 13.67 Mn
Sep 30, 2024 15.31 Mn
Jun 30, 2024 12.76 Mn
Mar 31, 2024 10.58 Mn
Dec 31, 2023 9.52 Mn
Sep 30, 2023 8.64 Mn
Jun 30, 2023 8.28 Mn
Mar 31, 2023 9.09 Mn
Dec 31, 2022 9.14 Mn
Sep 30, 2022 7.47 Mn
Jun 30, 2022 9.74 Mn
Mar 31, 2022 8.85 Mn
Dec 31, 2021 20.97 Mn
Sep 30, 2021 23.70 Mn
Jun 30, 2021 26.02 Mn